Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Jun 19;24(10):2072–2080. doi: 10.1016/j.bbmt.2018.06.013

Figure 2A, 2B: VOD Incidence Among Four Risk Groups in Training and Validation Cohorts.

Figure 2A, 2B:

Figure 2A shows the incidence of VOD in the training set for each of the 4 risk groups (A-D). Figure 2B shows the incidence of VOD in the validation set for each of the 4 risk groups (A-D). The curves are labeled with the cumulative incidence by day+100 in each of the 4 risk groups (A-D).